Idexx Laboratories (IDXX) Accounts Payables (2009 - 2026)

Idexx Laboratories has reported Accounts Payables for 18 years, with the latest figure at $129.1 million in Q2 2026.

• On a quarterly basis, Accounts Payables rose 10.73% year-over-year to $129.1 million in Q2 2026; TTM through Jun 2026 was $129.1 million, a 10.73% increase from a year earlier, with the FY2025 full-year figure at $110.4 million, down 3.33% from the prior year.
• Accounts Payables was $129.1 million for Q2 2026 at Idexx Laboratories, down from $130.0 million in the prior quarter.
• The five-year high for Accounts Payables was $130.0 million in Q1 2026, with the low at $107.7 million in Q2 2023.
• Average Accounts Payables over 5 years is $117.0 million, with a median of $117.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables surged 38.66% in 2022, then dropped 15.4% in 2023.
• Over 5 years, Accounts Payables stood at $110.2 million in 2022, then rose by 0.38% to $110.6 million in 2023, then gained by 3.22% to $114.2 million in 2024, then retreated by 3.33% to $110.4 million in 2025, then rose by 16.93% to $129.1 million in 2026.
• The last three Accounts Payables figures came in at $129.1 million (Q2 2026), $130.0 million (Q1 2026), and $110.4 million (Q4 2025), per Business Quant data.